FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy

SPOTLIGHT: Wyeth sues Watson to quash generic

March 14, 2008 — 7:59am ET
Tools


It's Watson Pharmaceuticals and Wyeth in the ring, as Watson filed for FDA approval to sell a generic version of Lybrel, a birth control pill, and Wyeth responded by suing for patent infringement. Report, Report

Be the first to comment
More stories about birth control   FDA   Watson Pharmaceuticals   FDA approval   Wyeth  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 45 + 23?
To combat spam, please solve the math question above.